8-KThe WireRoutine
Reg FD Disclosure
Filed Mar 9, 2026 · 3mo ago · Accession 0001193125-26-097548
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Kalaris Therapeutics, Inc.
- Ticker
- KLRS
- CIK
- 1754068
- Form type
- 8-K
- Filing date
- Mar 9, 2026
- Report date
- Mar 9, 2026
- Document
- d122695d8k.htm
- Size
- 6.1 MB